These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16400972)

  • 1. [New strategies in cardiovascular prevention].
    Moreno J; Alegría-Barrero E; Cordero A; Fernández-Jarne E; Sáenz de Buruaga JD
    Rev Med Univ Navarra; 2005; 49(3):9-15. PubMed ID: 16400972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging risk factors for cardiovascular disease: a review of the epidemiologic evidence for lipoprotein(a), homocysteine, and fibrinogen.
    Catena C; Cavarape A; Dotto L; Colussi G; Novehllo M; De Marchi S; Sechi LA
    Adv Clin Path; 2003 Jan; 7(1):3-11. PubMed ID: 19774732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk functions and the primary prevention of cardiovascular disease].
    Grau M; Marrugat J
    Rev Esp Cardiol; 2008 Apr; 61(4):404-16. PubMed ID: 18405521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease risk factors in polycystic ovary syndrome.
    Dokras A
    Semin Reprod Med; 2008 Jan; 26(1):39-44. PubMed ID: 18181081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first SHAPE (Screening for Heart Attack Prevention and Education) guideline.
    Naghavi M; Falk E; Hecht HS; Shah PK;
    Crit Pathw Cardiol; 2006 Dec; 5(4):187-90. PubMed ID: 18340236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recommendations for the control of cholesterolemia in Spain].
    Villar Alvarez F; Mata López P; Plaza Pérez I; Pérez Jiménez F; Maiques Galán A; Casasnovas Lenguas JA; Banegas Banegas JR; Abadal LT; Rodríguez Artalejo F; Gil López E
    Rev Esp Salud Publica; 2000; 74(5-6):457-74. PubMed ID: 11217236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic syndrome and cardiovascular disease.
    Bonora E
    Ann Med; 2006; 38(1):64-80. PubMed ID: 16448990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.
    Naghavi M; Falk E; Hecht HS; Jamieson MJ; Kaul S; Berman D; Fayad Z; Budoff MJ; Rumberger J; Naqvi TZ; Shaw LJ; Faergeman O; Cohn J; Bahr R; Koenig W; Demirovic J; Arking D; Herrera VL; Badimon J; Goldstein JA; Rudy Y; Airaksinen J; Schwartz RS; Riley WA; Mendes RA; Douglas P; Shah PK;
    Am J Cardiol; 2006 Jul; 98(2A):2H-15H. PubMed ID: 16843744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional and emerging risk factors for cardiovascular disease.
    Eaton CB
    Prim Care; 2005 Dec; 32(4):963-76, vii. PubMed ID: 16326222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity in childhood and cardiovascular risk.
    Burke V
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):831-7. PubMed ID: 16922816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediterranean diet and metabolic diseases.
    Giugliano D; Esposito K
    Curr Opin Lipidol; 2008 Feb; 19(1):63-8. PubMed ID: 18196989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and risk stratification of patients with the metabolic syndrome and diabetes.
    Wong ND
    Expert Rev Cardiovasc Ther; 2006 Mar; 4(2):181-90. PubMed ID: 16509814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The best of epidemiology and cardiovascular prevention in 2006].
    Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus.
    Irons BK; Greene RS; Mazzolini TA; Edwards KL; Sleeper RB
    Pharmacotherapy; 2006 Feb; 26(2):168-81. PubMed ID: 16466323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular prevention of high risk patients by hypolipidemic treatment].
    Moulin P; Sérusclat A; Bernard S
    Rev Prat; 2005 Oct; 55(16):1783-7. PubMed ID: 16363428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing cardiovascular disease in Kentucky: epidemiology, trends, and strategies for the future.
    Rugg SS; Bailey AL; Browning SR
    J Ky Med Assoc; 2008 Apr; 106(4):149-61; quiz 149, 162-3. PubMed ID: 18478845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in obesity related cardiovascular risk factors in Spain.
    Cordero A; León M; Andrés E; Ordoñez B; Laclaustra M; Grima A; Pascual I; Luengo E; Civeira F; Pocoví M; Alegría E; Casasnovas JA;
    Prev Med; 2009 Feb; 48(2):134-9. PubMed ID: 19038283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.